Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.33601Source: DataRank Database

Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018 is a research paper published in JAMA Network Open (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (26)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Reshma Ramachandran ORCID,Till Brückner ORCID,Joseph S. Ross ORCID,Joshua D. Wallach ORCID

Live enrichment

PubMed:34751764 PMC:PMC8579231

NCATS NIH HHS

Grant: UL1 TR001863

NIAAA NIH HHS

Grant: K01 AA028258

National Institutes of Health

Grant: 5K01AA028258-04

Identifying patient subgroups that are most likely to benefit from medications used to treat alcohol use disorder

goldLicense: cc-by

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2785883/wallach_2021_ld_210242_1635436984.36678.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8579231

Europe_PMChttps://europepmc.org/articles/PMC8579231

https://doi.org/10.1001/jamanetworkopen.2021.33601

https://pubmed.ncbi.nlm.nih.gov/34751764

Fields of Study

03 medical and health sciences0302 clinical medicine0101 mathematics01 natural sciencesClinical Trials as TopicDrug ApprovalDrug IndustryHumansProduct Surveillance, PostmarketingUnited StatesUnited States Food and Drug Administration

MeSH Terms

HumansDrug ApprovalProduct Surveillance, PostmarketingUnited States Food and Drug AdministrationDrug IndustryUnited StatesClinical Trials as Topic

Keywords

Clinical Trials as TopicDrug IndustryUnited States Food and Drug AdministrationResearch LetterProduct Surveillance, PostmarketingHumansDrug ApprovalUnited States

Sustainable Development Goals

SDG 3: 3. Good health